APLS
Apellis Pharmaceuticals Inc
Price:  
17.96 
USD
Volume:  
1,824,371.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Apellis Fair Value

-143.89 %
Upside

What is the fair value of Apellis?

As of 2025-04-29, the Fair Value of Apellis Pharmaceuticals Inc (APLS) is -7.88 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.96 USD, the upside of Apellis Pharmaceuticals Inc is -143.89%.

Is Apellis a good investment?

With the market price of 17.96 USD and our fair value calculation, Apellis Pharmaceuticals Inc (APLS) is not a good investment. Investing in Apellis stocks now will result in a potential loss of 143.89%.

Note: valuation result may not be accurate due to the company's negative EPS.

17.96 USD
Stock Price
-7.88 USD
Fair Price
FAIR VALUE CALCULATION

Apellis Fair Value

Peter Lynch's formula is:

Apellis Fair Value
= Earnings Growth Rate x TTM EPS
Apellis Fair Value
= 5.00 x -1.58
Apellis Fair Value
= -7.88

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -344.90 -746.40 -652.20 -528.63 -197.88 -494.00
YoY growth -13.19% -116.41% 12.62% 18.95% 62.57% -7.09%

Apellis Fair Value - Key Data

Market Cap (mil) 2,254.34
P/E
Forward P/E
EPS -1.58
Avg earnings growth rate -7.09%
TTM earnings -197.88